Poor response to thiopurine in inflammatory bowel disease: how to overcome therapeutic resistance?

Chouchana, Laurent; Roche, Denis; Jian, Raymond; Beaune, Philippe; Loriot, Marie-Anne

Chouchana, Laurent; Roche, Denis; Jian, Raymond; Beaune, Philippe; Loriot, Marie-Anne.

Affiliation

Chouchana L; Assistance publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Biochimie, Pharmacogénétique et Oncologie Moléculaire, Paris, France.

Clin Chem ; 59(7): 1023-6, 2013 Jul.

Article in En | MEDLINE | ID: mdl-23813427

Subject(s)

Azathioprine/therapeutic use; Colitis, Ulcerative/drug therapy; Immunosuppressive Agents/therapeutic use; Mercaptopurine/therapeutic use; Adalimumab; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Azathioprine/adverse effects; Azathioprine/blood; Drug Resistance; Female; Humans; Immunosuppressive Agents/adverse effects; Immunosuppressive Agents/blood; Infliximab; Mercaptopurine/adverse effects; Mercaptopurine/blood; Recurrence; Treatment Failure; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azathioprine / Colitis, Ulcerative / Immunosuppressive Agents / Mercaptopurine Limits: Adult / Female / Humans Language: En Journal: Clin Chem Journal subject: QUIMICA CLINICA Year: 2013 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google